中国巨石 reported revenue of ¥11.16B for the period ended 2026-06-30, +22.5% year on year. Net income was ¥3.03B, a 27.1% net margin on a 42.1% gross margin. The largest revenue line is 玻纤及其制品相关 at 97% of the total. Free cash flow for the period was ¥0.60B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥11.16B | +22.5% |
| Gross profit | ¥4.70B | — |
| Operating income | ¥3.61B | — |
| Net income | ¥3.03B | +72.3% |
| Gross margin | 42.1% | Net margin 27.1% |
| Revenue Q/Q | +11.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 玻纤及其制品相关 | ¥10.86B | 97.3% |
| 其他(补充) | ¥0.21B | 1.9% |
| 其他 | ¥0.09B | 0.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥6.46B | 57.9% |
| R&D | ¥0.35B | 3.1% |
| SG&A | ¥0.47B | 4.2% |
| Tax & other | ¥0.58B | 5.2% |
| Item | Amount |
|---|---|
| Total assets | ¥57.65B |
| Total liabilities | ¥22.99B |
| Shareholders' equity | ¥34.66B |
| Equity / assets | 60.1% |
| Operating cash flow | ¥2.20B |
| Capital expenditure | ¥1.60B |
| Free cash flow | ¥0.60B |
| Cash conversion (OCF / net income) | 80% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
生益科技 ・ 兖矿能源 ・ 复星医药 ・ 南山铝业 ・ 海航控股 ・ 圆通速递 ・ 恒瑞医药 ・ 万华化学 ・ 恒力石化 ・ 江西铜业 ・ 中航机载 ・ 国电南瑞
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies